throbber
Frequently Asked Questions About LUMIFY® Eye Drops
`
`hnps://v.~vw.lumifydrops.com/faqs
`
`Professionals click he re
`
`LUMTFY~
`
`REDNESS RELIEVER EYE DROPS
`
`=
`
`What are LUMIFY eye drops?
`
`LUMI FY is an eye drop that can be used for eye redness relief caused by minor eye irritat ions.
`
`Can I use LUMIFY eye drops with my contacts?
`
`LUMIFY can be used with contacts, but be sure to take them out before putting LUMIFY in your
`eyes. Wait 10 minutes before putting your contacts back in after use of LUM I FY.
`
`Can I use it with other eye drops?
`
`Yes, but you'll want to wait at least 5 minutes bet ween products.
`
`I of 4
`
`7/'2:2./2022, 3:39 PM
`
`Eye Therapies Exhibit 2108, 1 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Frequently Asked Questions About LUMIFY® Eye Drops
`
`hnps://v.~vw.lumifydrops.com/faqs
`
`Professionals click h ere
`
`LUMTFY"
`
`REDNESS RELIEVER EYE DROPS
`
`=
`
`How do LUMIFY eye drops work differently?
`
`• LUM IFY is FDA approved and is the first and only over the counter eye drop to contain the active
`ingredient brimonidine tart rate (0.025%).
`• LUM IFY works d ifferently than other redness relievers on the market by selectively targeting
`redness and in clinical t ri als was safe and effective when used as directed.
`
`What makes my eyes red?
`
`Occasional eye redness, sometimes referred to as "blood shot", is a common condition that can be
`caused by minor eye irritation. Common causes include environment al allergens, excessive use of
`digital devices, lack of sleep, or dry and/or dusty condit ions.
`
`Who is Bausch + Lomb?
`
`Bausch + Lomb is a leading g lobal eye health organization t hat is solely focused on protecting and
`restoring people's eyesight. Its core businesses include over-the-counter supplements, eye care
`products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical
`devices and instruments
`
`What is Brimonidine Tartrate (0.025%)?
`
`Brimonidine tartrate is the active ingredient in LUMIFY. Low dose brimonidine selectively constricts
`the veins in the eye as opposed to arteries thereby providing effective redness relief with low
`incidence of side effects associated with other redness relievers when used as directed. Brimonidine
`is NOT a bleach or a dye.
`
`How long will they last?
`
`In clinical trials, LUM I FY provided significant redness reduction for up to 8 hours.
`
`Is LUMIFY FDA approved? What does it mean to be FDA approved?
`
`LUMIFY has been approved for distribution by the FDA after review of our clinical trial program, in
`which six clinical studies were conducted to evaluate the safety and effectiveness of LUMIFY
`(brimonidine tartrate, 0.025%) in relieving ocular redness.
`
`How long will a bottle last?
`
`How long the bottle lasts will depend on how frequently you use it. Once eye drops have been
`opened, they risk being contaminated with bacteria. Therefore, it is recommended that you throw
`away any opened bottles of eye drops after 3 months, even if the expiration date is later. You also
`should never share eye drops - eye infections can be spread this way.
`
`How often can I use LUMIFY? Can LUMIFY be used daily?
`
`Instill one drop in each eye that needs it every 6-8 hours. Don't use more than 4 times a day. As with
`other OTC redness relievers, you should stop use and ask a doctor if you experience eye pain,
`changes in vision, redness or irritation that worsens or lasts more than 72 hours (3 days).
`
`2 of 4
`
`7/'2:2./2022, 3:39 PM
`
`Eye Therapies Exhibit 2108, 2 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Frequently Asked Questions About LUMIFY® Eye Drops
`
`hnps://v.~vw.lumifydrops.com/faqs
`
`Professionals click h ere
`
`LUMTFY"
`
`REDNESS RELIEVER EYE DROPS
`
`=
`
`How do I use LUMIFY?
`
`For adults and children 5 years of age and over:
`
`• instill 1 drop in the affected eye(s) every 6-8 hours
`• do not use more than 4 times daily
`• remove contact lenses before use
`• wait at least 10 minutes before re-inserting contact lenses after use
`• if using other ophthalmic products while using this product, wait at least 5 minutes between each
`product
`• to avoid contamination, do not touch t ip of container to any surface
`• replace the bottle cap after each use
`• if you are using a single use dispenser, d iscard dispenser immediately after use
`
`For children under 5 years of age, consult your doctor.
`
`I have more questions. Who can I ask?
`
`To speak with someone about additional questions, or to report any concerns with Bausch + Lomb
`Products, please call 800-553-5340. You can also talk to your eye doctor for additional information.
`
`What is in WMIFY?
`
`The active ingredient in LUMIFY is brimonidine tartrate (0.025%). The inactive ingredients in LUM I FY
`are: benzalkonium chloride, boric acid, calcium chloride dihydrate, glycerin, potassium chloride,
`sodium borate decahydrate, sodium chloride, water for injection. Hydrochloric acid and/or sodium
`hydroxide may be used to adjust p H.
`
`Are LUMIFY eye drops safe for your eyes? Can there be side effects?
`
`In clinical trials, LUM I FY was proven to be safe and effective when used as directed. LUM I FY works
`differently than other redness relievers by selectively targeting redness with a reduced risk of side
`effects associated with other redness relievers, including rebound redness and loss of efficacy over
`time. In clinical trials, a small number of people reported itching, foreign body sensation, tearing
`and pain which were temporary and mild to moderate in severity. We ask that you report any
`concerns with Bausch + Lomb Products via phone at 800-553-5340. Always be sure to follow the
`directions for use on the package when using LUMIFY.
`
`Is LUMIFY for dry eyes?
`
`LUMIFY should only be used to relieve red eyes due to minor eye irritations.
`
`Is LUMIFY safe during pregnancy or while breast-feeding?
`
`LUMIFY has not been tested on pregnant or lactating women. If pregnant or breast-feeding, ask a
`healthcare professional before use.
`
`Where can I buy LUMIFY?
`
`3 of 4
`
`7/'2:2./2022, 3:39 PM
`
`Eye Therapies Exhibit 2108, 3 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Frequently Asked Questions About LUMIFY® Eye Drops
`
`hnps://v.~vw.lumifydrops.com/faqs
`
`Professionals click h ere
`
`LUMTFY"
`
`REDNESS RELIEVER EYE DROPS
`
`=
`
`Over-the-counter medicines, including LUMIFY, are FSA eligible with a doctor's prescription.
`
`The Science of LUMIFY
`~ SEE MORE
`
`The LUMIFY Buzz
`
`S EE MOR E ➔
`
`Become a LUMIFY lover for inside info, beauty tips, events, coupons, and morel Learn more >
`
`SIGN UP
`
`4 of 4
`
`7/'2:2./2022, 3:39 PM
`
`Eye Therapies Exhibit 2108, 4 of 4
`Slayback v. Eye Therapies - IPR2022-00142
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket